Anderson Schock
Stock Analyst at B. Riley Securities
(0.57)
# 4,120
Out of 5,179 analysts
8
Total ratings
42.86%
Success rate
-20.41%
Average return
Main Sectors:
Stocks Rated by Anderson Schock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Reiterates: Buy | $28 → $11 | $6.60 | +66.67% | 1 | Mar 6, 2026 | |
| SPOK Spok Holdings | Downgrades: Neutral | $21 → $14 | $11.08 | +26.35% | 1 | Feb 26, 2026 | |
| MBOT Microbot Medical | Initiates: Buy | $5 | $2.39 | +109.21% | 1 | Feb 10, 2026 | |
| XGN Exagen | Reiterates: Buy | $18 → $8 | $2.68 | +198.51% | 3 | Jan 30, 2026 | |
| VREX Varex Imaging | Reiterates: Buy | $16 | $10.73 | +49.11% | 1 | Nov 19, 2025 | |
| INGN Inogen | Initiates: Buy | $14 | $6.19 | +126.17% | 1 | Jun 16, 2025 |
OptimizeRx
Mar 6, 2026
Reiterates: Buy
Price Target: $28 → $11
Current: $6.60
Upside: +66.67%
Spok Holdings
Feb 26, 2026
Downgrades: Neutral
Price Target: $21 → $14
Current: $11.08
Upside: +26.35%
Microbot Medical
Feb 10, 2026
Initiates: Buy
Price Target: $5
Current: $2.39
Upside: +109.21%
Exagen
Jan 30, 2026
Reiterates: Buy
Price Target: $18 → $8
Current: $2.68
Upside: +198.51%
Varex Imaging
Nov 19, 2025
Reiterates: Buy
Price Target: $16
Current: $10.73
Upside: +49.11%
Inogen
Jun 16, 2025
Initiates: Buy
Price Target: $14
Current: $6.19
Upside: +126.17%